cetuximab
This drug is selected. Its supporting articles are shown below.
Articles mentioning cetuximab
17 articles · page 1 of 2…n and cytolytic activity of PBMCs against SNU-503 and NCI-H508. Ficerafusp alfa showed prolonged and significantly improved tumor cytotoxicity …
…follow-up.Conclusions Our findings indicate that Dabrafenib and cetuximab with chemotherapy are effective and tolerable first-line and se…
…d OS of 13.4 months,38 39 leading to full FDA approval in 2024. Adagrasib has also shown modest activity in PDAC (ORR 33%, PFS 5.4 months…
…al immunotherapy approaches to date.Conclusions Taken together, TTX-080 offers a differentiated mechanism-of-action that has the potent…
…uctured pharmacist-led follow-up. The excellent tolerability of XELOX, with no need for rescue therapy, suggests this subgroup could …
…umab) are often used in ovarian and cervical cancers. ICIs (eg, pembrolizumab) are effective in mismatch repair-deficient endometrial cancer …
…e completed successfully. Forty-one patients with rGBM received bevacizumab-SIACI, 7 with ndGBM bevacizumab-SIACI, and 22 with ndGBM cetuximab-SI…
…able engagement by tumor cell-opsonizing antibodies. Therefore, F9H4 represents a new opportunity in cancer immunotherapy research.E…
…ls, which decreased upon pre-treatment (receptor blockade) with cetuximab. Secondly, immunofluorescence staining for γH2Ax foci noted tha…
…), atezolizumab (Tecentriq), osimertinib (Tagrisso), ceritinib (Zykadia) and nintedanib (Vargatef). EMA labels for all products include…
…ROP2, or EGFR Boosters demonstrated superior tumor control than trastuzumab, sacituzumab, or cetuximab analogue treated mice respectively. …